Dr. Mikhail Blagosklonny and His Vigilant Fight Against Ageing

Dr. Blagosklonny has been interested in the world of medicine from a very young age, explaining why he acquired both his M.D. in Internal Medicine and Ph.D. in experimental medicine and cardiology from the First Pavlov State Medical University Of St. Petersburg. His performance was so exemplary to the point that he qualified for a job at New York Medical College in Valhalla as an associate professor in 2002.Once he was done with that, Dr. Blagosklonny went on to challenge himself with a position in Ordway Research Institute as a Senior Scientist right before ending up at Roswell Park Cancer Institute as an Oncology Professor in 2009. That was when his research in rapamycin intensified and made enormous progress.Dr. Blagosklonny has been in the business of making sure that he finds much better and less invasive ways of treating cancer. He ensured that he was always in a position to get work done by developing an anti aging drug called rapamycin, one that he later wrote a paper on about how it can be utilized properly.

Dr. Blagosklonny wrote that the use of rapamycin would go a long way in slowing the aging rate as it targets particular cells that trigger the latter hence making the entire process slower. In layman terms, the medication has some rather straightforward modus operandi which acts on the principle of protecting healthy cells from damage as the cancer cells are attacked.The use of rapamycin, Dr. Blagosklonny stated, will most likely affect the TOR signaling in aging and cancer, which can without a doubt boost the lifespan of the consumer. He attributed old age to cells being damaged, and since our bodies to rejuvenate them as fast as possible, they die off at a much faster rate than normal which is the cause of aging.When healthy cells are protected, then the body functions will always work which will result in a boost in the immune system. And since he had spent a couple of years studying bio gerontology (which is the science of studying the underlying body mechanisms that result to aging).

Dr. Blagosklonny has been able to consider the kind of effects that patients who consume rapamycin are having, both in the short and long term.Apart from being an adroit researcher and scientist, Dr. Blagosklonny is also known for his impressive writing as reflected in quite some publications that sparked a worldwide interest once published. Some of his publications include Cancer Biology & Therapy where he was both a contributor and editor.In total, the brilliant oncology specialist has written close to 270 pages in total, making sure that he shares his knowledge with millions of people around the globe. The latter has resulted to his effective outsourcing over 25,000 citations over the years.Others include Aging, where he was the editor in chief as well as Oncotarget. He also was the editor in chief in Cell Cycle after he carried out an in-depth research on the subject matter. In all the above publications, all of which Dr. Blagosklonny (@Mikhail Blagosklonny) is responsible for making happen, he always made sure that he recommends the use of rapamycin.

Leave a Reply